Antigen presenting phenotype of hodgkin reed-sternberg cells: Analysis of the HLA class I processing pathway and the effects of interleukin-10 on Epstein-Barr virus-specific cytotoxic T-cell recognition

Blood

Volumn 92, Issue 3, 1998, Pages 1020-1030

  Lee, Steven P ^a   Constandinou, Christothea M ^b   Thomas, Wendy A ^b   Croom Carter, Debbie ^b   Blake, Neu W ^b   Murray, Paul G ^b   Crocker, John ^b   Rickinson, Alan B ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; INTERLEUKIN 10;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; REED STERNBERG CELL;

EID: 0032147126     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.1020.415a20_1020_1030     Document Type: Article

References (49)

1. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O'Grady J, Hummel M, Preciado MV, Knecht H, Chan JC, Claviez A: Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 70:375, 1997
2. Boiocchi M, Dolcetti R, Dere V, Gloghini A, Carbone A: Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease. Am J Pathol 142:33, 1993
3. Rickinson AB, Kieff E: Epstein-Barr virus, in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, PA, Lippincott, 1996, p 2397
4. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ: Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia - Implications for vaccine development. J Exp Med 176:169, 1992
5. Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB: HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol 67:7428, 1993
6. Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB: Conserved CTL epitopes within EBV latent membrane protein 2 - A potential target for CTL-based tumor therapy. J Immunol 158:3325, 1997
7. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB: Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) - Implications for the immune control of EBV-positive malignancies. J Exp Med 176:157, 1992
8. Rooney CM, Smith CA, Ng CC, Loftin S, Li CF, Krance RA, Brenner MK, Heslop HE: Use of gene modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9, 1995
9. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS: Epstein-Barr virus and Hodgkin's disease - Transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339, 1993
10. Pallesen G, Hamiltondutoit SJ, Rowe M, Young LS: Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 337:320, 1991
11. Grasser FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W, Reynolds G, Niedobitek G, Young LS, Muellerlantzsch N: Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1) - Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 84:3792, 1994
12. Niedobitek G, Kremmer E, Herbst H, Whitehead L, Dawson CW, Niedobitek E, vonOstau C, Rooney N, Grasser FA, Young LS: Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood 90:1664, 1997
13. Frisan T, Sjoberg J, Dolcetti R, Boiocchi M, Dere V, Carbone A, Brautbar C, Battat S, Biberfeld P, Eckman M, Ost O, Christensson B, Sundstrom C, Bjorkholm M, Pisa P, Masucci MG: Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86:1493, 1995
14. Sing AP, Ambinder RF, Hong DJ, Jensen M, Batten W, Petersdorf E, Greenberg PD: Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: Implications for immune-mediated therapy of EBV(+) Hodgkin's disease. Blood 89:1978, 1997
15. York IA, Rock KL: Antigen processing and presentation by the class I Major Histocompatibility Complex. Annu Rev Immunol 14:369, 1996
16. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mule JJ, Rosenberg SA, Bennink JR: Identification of human cancers deficient in antigen processing. J Exp Med 177:265, 1993
17. Khanna R, Burrows SR, Argaet V, Moss DJ: Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumor cell line. Int Immunol 6:639, 1994
18. Poppema S, Visser L: Absence of HLA class I expression by Reed-Sternberg cells. Am J Pathol 145:37, 1994
19. Oudejans JJ, Jiwa NM, Kummer JA, Horstman A, Vos W, Baak JA, Kluin PM, Vandervalk P, Walboomers JM, Meijer CM: Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T cell response in Epstein-Barr virus-positive and Epstein-Barr virus-negative Hodgkin's disease. Blood 87:3844, 1996
20. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, Ogarra A: IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444, 1991
21. Malefyt RD, Haanen J, Spits H, Roncarolo MG, Tevelde A, Figdor C, Johnson K, Kastelein R, Yssel H, Devries JE: Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 174:915, 1991
22. Taga K, Mostowski H, Tosato G: Human interleukin 10 can directly inhibit T cell growth. Blood 81:2964, 1993
23. Herbst H, Foss HD, Samol J, Araujo I, Klotzbach H, Krause H, Agathanggelou A, Niedobitek G, Stein H: Frequent expression of interleukin 10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 87:2918, 1996
24. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R: Interleukin 10 pretreatment protects target cells from tumor-specific and allo-specific cytotoxic T cells and down-regulates HLA class I expression. J Exp Med 180:2371, 1994
25. Lukes RJ, Carver LF, Hall TC, Rappaport H, Ruben P: Report of the nomenclature committee. Cancer Res 26:1311, 1966
26. Diehl V, Kirchner HH, Schaadt M, Fonatsch C, Stein H, Gerdes J, Boie C: Hodgkin's disease - Establishment and characterization of 4 in vitro cell lines. J Cancer Res Clin Oncol 101:111, 1981
27. Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shirakawa S, Hatanaka M, Honjo T: Cytochemical, immunological, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood 68:285, 1986
28. Drexler HG, Gaedicke G, Lok MS, Diehl V, Minowada J: Hodgkin's disease derived cell lines HDLM-2 and L-428 - Comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10:487, 1986
29. Kanzler H, Hansmann ML, Kapp U, Wolf J, Diehl V, Rajewsky K, Kuppers R: Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin Reed-Sternberg cells of a Hodgkin's lymphoma patient. Blood 87:3429, 1996
30. Murray PG, Young LS, Rowe M, Crocker J: Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol 166:1, 1992
31. Stam NJ, Spits H, Ploegh HL: Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137:2299, 1986
32. Kelly A, Powis SH, Kerr LA, Mockridge I, Elliott T, Bastin J, Uchanskaziegler B, Ziegler A, Trowsdale J, Townsend A: Assembly and function of the 2 ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355:641, 1992
33. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A: Production of monoclonal antibodies to Group A erythrocytes, HLA and other human cell surface antigens - New tools for genetic analysis. Cell 14:9, 1978
34. Parham P, Brodsky FM: Partial purification and some properties of BB7.2 - A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 3:277, 1981
35. Finerty S, Rowe M, Berry PJ, Ranson DL, Mott MG, Gregory CD, Rickinson AB: Burkitt-like lymphoma in an English child - Characterization of tumor biopsy cells and of the derived tumor cell line. Br J Cancer 54:385, 1986
36. Blasco R, Moss B: Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157, 1995
37. O'Neil BH, Kawakami Y, Restifo NP, Bennink JR, Yewdell JW, Rosenberg SA: Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA. J Immunol 151:1410, 1993
38. Hsu DH, Malefyt RD, Fiorentino DF, Dang MN, Vieira P, Devries J, Spits H, Mosmann TR, Moore KW: Expression of interleukin 10 activity by Epstein-Barr virus protein BCRF1. Science 250:830, 1990
39. Salter RD, Howell DN, Cresswell P: Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21:235, 1985
40. Cerundolo V, Alexander J, Anderson K, Lamb C, Cresswell P, McMichael A, Gotch F, Townsend A: Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 345:449, 1990
41. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR, Trowsdale J, Moss DJ, Rickinson AB: Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: Coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol 25:1374, 1995
42. Lee SP, Thomas WA, Blake NW, Rickinson AB: Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. Eur J Immunol 26:1875, 1996
43. Rooney CM, Rowe M, Wallace LE, Rickinson AB: Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T cell surveillance. Nature 317:629, 1985
44. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells.2. Continuous cell lines. Leuk Lymphoma 9:1, 1993
45. Wolf J, Kapp U, Bohlen H, Kornacker M, Schoch C, Stahl B, Mucke S, Vonkalle C, Fonatsch C, Schaefer HE, Hansmann ML, Diehl V: Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin Reed-Sternberg cells. Blood 87:3418, 1996
46. Qin ZH, Noffz G, Mohaupt M, Blankenstein T: Interleukin 10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J Immunol 159:770, 1997
47. Stewart JP, Rooney CM: The interleukin 10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses. Virology 191:773, 1992
48. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T: W15.1 reference tables, in Tsuji K, Aizawa M, Sasazuki T (eds): HLA-1991. Oxford, UK, Oxford University Press, 1992, p 1066
49. Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ: Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med 181:2221, 1995